KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells

• Yu-Lin Lin,

  Affiliations Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan

  ⨯
• Jau-Yu Liau ,

  Contributed equally to this work with: Jau-Yu Liau, Shan-Chi Yu

  Affiliation Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan

  ⨯
• Shan-Chi Yu ,

  Contributed equally to this work with: Jau-Yu Liau, Shan-Chi Yu

  Affiliation Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan

  ⨯
• Da-Liang Ou,

  Affiliations National Center of Excellence for Clinical Trial and Research, National Taiwan University Hospital, Taipei, Taiwan, Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan

  ⨯
• Liang-In Lin,

  Affiliations Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan, Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan

  ⨯
• Li-Hui Tseng,

  Affiliation Department of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan

  ⨯
• Yih-Leong Chang,

  Affiliations Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan, Department and Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan

  ⨯
• Kun-Huei Yeh ,

  * E-mail: khyeh@ntu.edu.tw

  Affiliations Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan, Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan

  ⨯
• Ann-Lii Cheng

  Affiliations Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan

  ⨯